• Research Tree
  • Features
  • Pricing
  • Events
  • Reg.News
  • Short Interest
  • Explore Content
    • Explore

      • Providers
        • Providers

          • Free/Commissioned
          • High Net Worth Offering
          • Institutional Offering

          Free/Commissioned

          Research that is free to access for all investors. Companies commission these providers to write research about them.

          View Research

          What is our Main Bundle Offering?

          Brokers who write research on their corporate clients and make it available through our main bundle offering.

          View Research

          What is Institutional?

          Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.

          View Research
      • Regions
        • Regions

          • UK
          • Rest of EMEA
          • N America
          • APAC
          • LatAm
      • Exchanges
        • Exchanges

          • Aquis Apex
          • Australian Securities Exchange
          • Canadian Securities Exchange
          • Euronext Paris
          • London Stock Exchange (domestic)
          • SIX Swiss Exchange
      • Sectors
        • Sector Coverage

          • Building & Construction
          • Discretionary Personal Goods
          • Discretionary Retail
          • Energy
          • Health
          • Investment Trusts
          • Media
          • Resources
          • Technology
      • Small / Large Cap
        • Small / Large Cap

          • UK100
          • UK250
          • UK Smallcap
          • UK Other Main Markets
          • Other
  • Login
  • Sign Up
LIVE

Event in Progress:

Join Here ×
  • 07 Sep 18
title

Most popular equity research this week | 3 - 7 Sep

  • 663 views
Rob Mundy

Helping investors and companies

 
SAFE Safestyle, Taptica TAP, FOOT Footasylum, IQE, SOM Somero Resources, Hurrican Energy, Sirius Minerals SXX, FDEV Frontier Developments
Strap line

See what's trending this week...

Companies: FOOT, FDEV, HUR, IQE, NEXN, 9WN, 73S, SEE, SXX, SOM


Body

Seeing Machines (SEE)

Fleet business update | Cenkos, 5 Sep

Paid Access

"Yesterday, Seeing Machines announced that following an initial review of the delays and cost over runs in its Gen2 fleet product, that it expected the production delays will have an ongoing adverse effect on growth of its connected base in FY19. Furthermore, the Board has concluded that the cost reductions previously anticipated to be delivered by the updated Guardian product are unlikely to be achieved in the short to medium-term..."



Taptica International (TAP)

Improving margins lead to another upgrade | finnCap, 4 Sep

Paid Access

"International expansion, notably in the Far East, together with the excellent Tremor acquisition, continues to drive revenue growth while margins are being improved by operating efficiencies. Furthermore, the $30m funding in H1 reduced debt and positioned Taptica for further earnings-enhancing M&A and discussions are already underway with targets. A winding-down of the legacy display business leads us to ease our revenue expectations slightly but the impressive growth and margins delivered suggest yet another earnings upgrade for this year, underpinning the upside in our target price..."



Somero Enterprises (SOM)

Interim results in line, with dividend doubled | finnCap, 5 Sep

Paid Access

"Half-year results were in line with guidance with few surprises. Market conditions remain favourable – with solid growth seen in the US and substantial growth in Europe. The interim dividend saw a one-off doubling, as the dividend was rebalanced with greater weighting to the interim pay-out. We are comfortable with our existing forecasts and maintain our price target at 465p. We continue to see positive market momentum and strong cash generation, with the development of new products offering a significant opportunity to deliver share price upside over the medium term..."



IQE (IQE)

Multiple VCSEL programmes entering production | Edison, 4 Sep

Free Access

"During H118 IQE experienced double-digit sales growth on a constant currency basis in each of its three primary markets, although this was partly offset by a currency headwind. The investment in multiple VCSEL qualifications and the Newport foundry depressed margins, but underpins management’s expectations of a sustained photonics ramp-up in H218 and FY19. Acknowledging the currency headwind and one-off H118 photonics costs, we revise our estimates downwards..."



Frontier Developments (FDEV)

Stacking franchises | Liberum, 5 Sep

Paid Access

"Frontier Developments has reported FY'18 revenues of £34.2m, in line with our forecasts, and adj. EBITDA of £9.4m 9% above. Frontier has announced franchise IV is expected to be released in FY'20 with 2 more franchises in early development..."



Hurricane Energy (HUR)

First thoughts: Spirit Energy farm-in | Edison, 3 Sep

Free Access

"Spirit Energy has farmed-in to 50% of Hurricane’s Lincoln and Warwick licences covering the Greater Warwick Area (GWA). The farm-in is intended to accelerate the de-risking and monetisation of GWA, adding a new leg to the Hurricane business model that will run in parallel with the development of the Greater Lancaster Area (GLA). Under the transaction, Hurricane will retain a 50% working interest in GWA licences in return for a net carry of $137.2m..."



Safestyle UK (SFE)

Settlement reached with SafeGlaze | Liberum, 3 Sep

Paid Access

"Safestyle has announced today the settlement of claims against SafeGlaze, a very aggressive new entrant to the window industry. Under the settlement, SafeGlaze will be rebranded and its behaviour towards Safestyle representatives restrained..."



Footasylum (FOOT)

A further downward revision | Liberum, 3 Sep

Paid Access

"Downgrading for the second time this year is highly disappointing. Delays to new store openings and upsizes mean these are unlikely to contribute much ahead of Christmas..."



Sirius Minerals (SXX)

Capex increased, project de-risking | Liberum, 6 Sep

Paid Access

"Sirius has announced it will require a further $400m-$600m in Stage 2 financing, mainly relating increased costs from the Mineral Transport System tunnel. The NPV impact of the cost increase is <10%, however depending on the ultimate financing solution our NPV per share will reduce from £1.08 to between £0.75 and £1.00..."



Rosenblatt Group (RBGP)

Raising the bar | Cenkos, 3 Sep

Paid Access

"Rosenblatt is a City firm of solicitors with a reputation for handling complex cases across litigation, corporate law and real estate. It has transformed over the last 18 months, instilling a greater commercial focus and breaking free from the norms of the traditional law firm. We see current momentum continuing, forecasting adj EBITDA of £8.2m by FY20E. At IPO, the group raised a total of £43m (gross) at 95p p/s..."



Body Two

Body Three

Body Four

Body Five

The information contained within this post is based on personal experience and opinion and should not be considered as a recommendation to trade nor financial advice.

More Content

More Content

Morning Note – 15 May 2025

Companies: TXP FTC BGEO MHA NEXN

Cavendish

Most popular equity research this week | 27-31 March

Companies: SEEETOIGPIOMKBTAFRNTRAKDOTDFLYBBVXPBAGRCNWJGSYME7DIGSPESHAWGYSKYYWY

Research Tree

Nexxen - Record Q1, revenue & EBITDA +3% and +62% ahead

Companies: Nexxen International Ltd.

Cavendish

3 UK stocks exposed to the shifting AdTech landscape

Companies: RTHMADGRFNEXN

Research Tree

UK smallcap technology update - Oversold stocks - May 2025

Companies: TBLD SAAS NCC CNS FDEV TIG CYAN QTX SYS SBDS CODE BIG DEVO

Zeus Capital
next
 
Research Tree
Useful Links
  • Features
  • Pricing
  • RNS/Newswires Feeds
  • Providers Hub
  • Company Hub
  • Stock Pick League
  • Chrome Extension
  • iOS and Android Apps
Account
  • Login
  • Join Now
  • Contact
  • Follow us on Linkedin
  • Follow us on X

© Research Tree 2025

  • Apple Store
  • Play Store
  • Terms of Service
  • Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top
  • Home
  • Features
  • Pricing
  • Event Hub
  • Reg.News
  • Short Interest Tracker
  • Explore Content
    • Regions
      • UK
      • Rest of EMEA
      • N America
      • APAC
      • LatAm
    • Exchanges
      • Aquis Apex
      • Australian Securities Exchange
      • Canadian Securities Exchange
      • Euronext Paris
      • London Stock Exchange (domestic)
      • SIX Swiss Exchange
    • Sectors
      • Automobile Industry
      • Banks
      • Building & Construction
      • Chemicals
      • Discretionary Personal Goods
      • Discretionary Retail
      • Energy
      • ETFs
      • Financial Services
      • Food & Drink
      • Food Production
      • Health
      • Household Goods & DIY
      • Industrial Equipment, Goods & Services
      • Insurance & Reinsurance
      • Investment Trusts
      • Leisure, Tourism & Travel
      • Media
      • Open-ended Funds
      • Other
      • Real Estate
      • Resources
      • Staple Retail
      • Technology
      • Telecoms
      • Utilities
    • Small / Large Cap
      • UK100
      • UK250
      • UK Smallcap
      • UK Other Main Markets
      • Other
    • Private/EIS
      • EIS Single Company
      • EIS/SEIS Funds
      • IHT Products
      • SEIS Single Company
      • VCT Funds
  • Providers
    • Free/Commissioned
      • Acquisdata
      • Actinver
      • Actio Advisors
      • Asset TV
      • Atrium Research
      • Baden Hill
      • BlytheRay
      • BNP Paribas Exane - Sponsored Research
      • Bondcritic
      • Brand Communications
      • BRR Media
      • Calvine Partners
      • Capital Access Group
      • Capital Link
      • Capital Markets Brokers
      • Cavendish
      • Checkpoint Partners
      • Clear Capital Markets
      • Couloir Capital
      • Doceo
      • Edison
      • Engage Investor
      • Equity Development
      • eResearch
      • First Equity
      • Five Minute Pitch TV
      • focusIR
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • goetzpartners securities Limited
      • Golden Section Capital
      • GreenSome Finance
      • GSBR Research
      • H2 Radnor
      • Hardman & Co
      • Holland Advisors
      • Hypothesis Research
      • InterAxS Global
      • Kepler | Trust Intelligence
      • London Stock Exchange
      • Longspur Clean Energy
      • Mello Events
      • Messari Research
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Optimo Capital
      • Panmure Liberum
      • Paul Scott
      • Peel Hunt
      • PIWORLD (hosted by Progressive)
      • Proactive
      • Progressive Equity Research
      • Quantum Research Group
      • QuotedData
      • Research Dynamics
      • Research Tree
      • Resolve Research
      • SEAL Advisors Ltd
      • ShareSoc
      • Shore Capital
      • Sidoti & Company
      • Small Cap Consumer Research LLC
      • StockBox
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Edge Group
      • The Life Sciences Division
      • Trinity Delta
      • Turner Pope Investments
      • UK Investor Group
      • ValueTrack
      • Vox Markets
      • VRS International S.A. - Valuation & Research Specialists (VRS)
      • VSA Capital
      • Winterflood Securities
      • Yaru Investments
      • Yellowstone Advisory
      • Zacks Small Cap Research
      • Zeus Capital
    • High Net Worth Offering
      • Fox-Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Align Research
      • Allenby Capital
      • AlphaValue
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • Baptista Research
      • BNP Paribas Exane - Sponsored Research
      • Canaccord Genuity
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • First Berlin
      • First Equity
      • First Sentinel
      • Greenwood Capital Partners
      • Hannam & Partners
      • Hybridan
      • Kemeny Capital
      • Longspur Clean Energy
      • Louis Capital
      • Magnitogorsk Iron and steel works
      • Medley Global Advisors
      • Northland Capital Partners
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • QuotedData Professional
      • Shard Capital
      • ShareSoc
      • Shore Capital
      • Singer Capital Markets
      • SP Angel
      • Stanford Capital Partners
      • Stifel FirstEnergy
      • Stockdale Securities
      • Tamesis Partners
      • Tennyson Securities
      • The Life Sciences Division
      • Turner Pope Investments
      • VSA Capital
      • Whitman Howard
      • Yellowstone Advisory
      • Zeus Capital
    • Institutional Offering
      • Fox-Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Acquisdata
      • Allenby Capital
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • BNP Paribas Exane
      • Bondcritic
      • Canaccord Genuity
      • Capital Access Group
      • Capital Link
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • Edison
      • First Berlin
      • First Equity
      • First Sentinel
      • Five Minute Pitch TV
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • Golden Section Capital
      • Goodbody
      • Greenwood Capital Partners
      • Hannam & Partners
      • Holland Advisors
      • Hybridan
      • InterAxS Global
      • Investec Bank
      • Kepler | Trust Intelligence
      • Numis
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • Peel Hunt
      • QuotedData
      • QuotedData Professional
      • Research Dynamics
      • Research Tree
      • Shard Capital
      • Shore Capital
      • Sidoti & Company
      • Singer Capital Markets
      • Small Cap Consumer Research LLC
      • SP Angel
      • Stanford Capital Partners
      • Stifel
      • StockBox
      • Tamesis Partners
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Life Sciences Division
      • ValueTrack
      • Velocity Trade
      • VSA Capital
      • Winterflood Securities
      • Zacks Small Cap Research
      • Zeus Capital
  • Contact
  • Sign Up
  • Sign In